Radiopharmaceuticals for diagnosis and therapy
US8894974B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 11, 2007 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Nov 27, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a human patient is provided, including administering a radiolabeled form of a therapeutic agent to the patient at a first substantially non-therapeutically-effective dose, wherein pharmacological activity of the therapeutic agent is not due to radioactivity of the therapeutic agent. The method also includes determining information related to a biodistribution of the radiolabeled form of the therapeutic agent in the patient by performing a radioimaging procedure on the patient. Responsively to the information, a decision is made whether or not to treat the patient by administering the therapeutic agent to the patient. If the decision is made to treat the patient, the patient is treated by administering the therapeutic agent to the patient at a second therapeutically-effective dose. If the decision is made not to treat the patient, treatment of the patient with the therapeutic agent is withheld. Other embodiments are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.